290 related articles for article (PubMed ID: 11007778)
1. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
Heath RJ; Su N; Murphy CK; Rock CO
J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis.
Hoang TT; Schweizer HP
J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225
[TBL] [Abstract][Full Text] [Related]
3. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
4. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
Heath RJ; Li J; Roland GE; Rock CO
J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).
Marrakchi H; Dewolf WE; Quinn C; West J; Polizzi BJ; So CY; Holmes DJ; Reed SL; Heath RJ; Payne DJ; Rock CO; Wallis NG
Biochem J; 2003 Mar; 370(Pt 3):1055-62. PubMed ID: 12487627
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary X-ray crystallographic analysis of enoyl-ACP reductase III (FabL) from Bacillus subtilis.
Kim KH; Park JK; Ha BH; Moon JH; Kim EE
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):246-8. PubMed ID: 17329825
[TBL] [Abstract][Full Text] [Related]
11. Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli.
Heath RJ; Rock CO
J Biol Chem; 1995 Nov; 270(44):26538-42. PubMed ID: 7592873
[TBL] [Abstract][Full Text] [Related]
12. The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistance.
Zhu L; Bi H; Ma J; Hu Z; Zhang W; Cronan JE; Wang H
mBio; 2013 Oct; 4(5):e00613-13. PubMed ID: 24085780
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
Lee IH; Kim EJ; Cho YH; Lee JK
Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
[TBL] [Abstract][Full Text] [Related]
14. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
Zhu L; Lin J; Ma J; Cronan JE; Wang H
Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
Lu H; Tonge PJ
Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
[TBL] [Abstract][Full Text] [Related]
17. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
19. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
Lee JH; Park AK; Chi YM; Moon JH; Lee KS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
[TBL] [Abstract][Full Text] [Related]
20. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]